XOMA Corp.

{
  "main_header": {
    "sid": 1163005,
    "name": "XOMA Corp.",
    "stock_name": "XOMA Corp.",
    "full_name": "XOMA Corp.",
    "name_url": "stocks-analysis/xoma-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "24.92",
    "chg": -2.05,
    "chgp": "-7.6%",
    "dir": -1,
    "prev_price": "26.97",
    "mcapval": "337.69",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US98419J2069",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "98.4 k",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/xoma-corp-1163005-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "XOMA Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xoma-corp-changes-valuation-grade-from-risky-to-fair-amid-price-fluctuations-3707914",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/XOMACorp_valuationdot_3707914.png",
        "date": "2025-11-17 15:38:51",
        "description": "XOMA Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation, currently priced at $32.64. Over the past year, it has returned 9.24%, underperforming the S&P 500. The company operates at a loss, with unfavorable valuation metrics compared to its peers in the industry."
      }
    ],
    "total": 14,
    "sid": "1163005",
    "stock_news_url": "https://www.marketsmojo.com/news/xoma-corp-1163005"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

XOMA Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape

2025-11-17 15:38:51

XOMA Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has adjusted its valuation, currently priced at $32.64. Over the past year, it has returned 9.24%, underperforming the S&P 500. The company operates at a loss, with unfavorable valuation metrics compared to its peers in the industry.

Read full news article

View All News